Akoya Biosciences, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 26.49 million compared to USD 21.22 million a year ago. Net loss was USD 10.8 million compared to USD 18.88 million a year ago. Basic loss per share from continuing operations was USD 0.22 compared to USD 0.5 a year ago.
For the full year, revenue was USD 96.63 million compared to USD 74.86 million a year ago. Net loss was USD 63.32 million compared to USD 70.64 million a year ago. Basic loss per share from continuing operations was USD 1.43 compared to USD 1.87 a year ago. Diluted loss per share from continuing operations was USD 1.43 compared to USD 1.87 a year ago.